Alterations in drug disposition in older adults

Bibliography

• United Nations Department of Economic and Social Affairs Population Division. World population ageing 2013. United Nations publication, New York: 2013
   Google Scholar
• Fedarko NS. The biology of aging and frailty. Clin Geriatr Med 2011;27:27-37
   PubMed Web of Science ®Google Scholar
• Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol 1995;27:647-53
   PubMed Web of Science ®Google Scholar
• Higami Y, Shimokawa I. Apoptosis in the aging process. Cell Tissue Res 2000;301:125-32
   PubMed Web of Science ®Google Scholar
• McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-84
   PubMed Web of Science ®Google Scholar
• Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med 2012;28:273-86
   PubMed Web of Science ®Google Scholar
• Kirkwood TBL, Austad SN. Why do we age? Nature 2000;408:233-8
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004;57:6-14
   PubMed Web of Science ®Google Scholar
• Amella EJ. Presentation of illness in older adults. If you think you know what you’re looking for, think again. AORN J 2006;83:372-89
   PubMedGoogle Scholar
• Schmader KE, Baron R, Haanpaa ML, et al. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc 2010;85:S26-32
   PubMed Web of Science ®Google Scholar
• Schmucker D. Liver function and phase I drug metabolism in the elderly. Drugs Aging 2001;18:837-51
   PubMed Web of Science ®Google Scholar
• Hilmer SN. ADME-tox issues for the elderly. Expert Opin Drug Metab Toxicol 2008;4:1321-31
   PubMed Web of Science ®Google Scholar
• Nelson EA, Dannefer D. Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist 1992;32:17-23
   PubMed Web of Science ®Google Scholar
• Deneer VHM, Van Hemel NM. Is antiarrhythmic treatment in the elderly different?: a review of the specific changes. Drugs Aging 2011;28:617-33
   PubMed Web of Science ®Google Scholar
• Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008;64:183-99
   PubMed Web of Science ®Google Scholar
• Lehnert T, Heider D, Leicht H, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 2011;68:387-420
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Older Australia at a glance. AIHW; Canberra: 2007
   Google Scholar
• Prescriptions dispensed in the community. Statistics for 1996 to 2006. The Information Centre (Health Care), England: 2007
   Google Scholar
• Mangoni AA. Predicting and detecting adverse drug reactions in old age: challenges and opportunities. Expert Opin Drug Metab Toxicol 2012;8:527-30
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Hattis D, Russ A, Sonawane B. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ Health Perspect 2005;113:1243-9
   PubMed Web of Science ®Google Scholar
• Hochhaus G, Barrett JS, Derendorf H. Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century. J Clin Pharmacol 2000;40:908-17
   PubMed Web of Science ®Google Scholar
• Mangoni AA. The impact of advancing age on P-glycoprotein expression and activity: current knowledge and future directions. Expert Opin Drug Metab Toxicol 2007;3:315-20
   PubMed Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;41:67-76
   PubMed Web of Science ®Google Scholar
• Feldman M. The mature stomach: still pumping out acid? JAMA 1997;278:681-2
   PubMed Web of Science ®Google Scholar
• Blechman MB, Gelb AM. Aging and gastrointestinal physiology. Clin Geriatr Med 1999;15:429-38
   PubMed Web of Science ®Google Scholar
• Hurwitz A, Brady DA, Schaal S, et al. Gastric acidity in older adults. JAMA 1997;278:659-62
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ogoshi K, Makuuchi H. Influence of aging, gastric mucosal atrophy and dietary habits on gastric secretion. Hepatogastroenterology 2006;53:624-8
   PubMed Web of Science ®Google Scholar
• Geller AM, Zenick H. Aging and the environment: a research framework. Environ Health Perspect 2005;113:1257-62
   PubMed Web of Science ®Google Scholar
• Schmucker D. Aging and drug disposition: an update. Pharmacol Rev 1985;37:133-48
   PubMed Web of Science ®Google Scholar
• Hurwitz A, Ruhl CE, Kimler BF, et al. Gastric function in the elderly: effects on absorption of ketoconazole. J Clin Pharmacol 2003;43:996-1002
   PubMed Web of Science ®Google Scholar
• Stangier J, Stahle H, Rathgen K, Fuhr R. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects. Clin Pharmacokinet 2008;47:47-59
   PubMed Web of Science ®Google Scholar
• Gidal BE. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res 2006;68(Suppl 1):S65-9
   PubMed Web of Science ®Google Scholar
• Abruzzo CW, Macasieb T, Weinfeld R, et al. Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastric pH. J Pharmacokinet Biopharm 1977;5:377-90
   PubMedGoogle Scholar
• O’Mahony D, O’Leary P, Quigley EM. Aging and intestinal motility. Drugs Aging 2002;19:515-27
   PubMed Web of Science ®Google Scholar
• Drozdowski L, Thomson AB. Aging and the intestine. World J Gastroenterol 2006;12:7578-84
   PubMed Web of Science ®Google Scholar
• Wilding I, Davis S, Hardy J, et al. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers. Br J Clin Pharmacol 1991;32:573-9
   PubMed Web of Science ®Google Scholar
• Yeh K, August T, Bush D, et al. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Neurology 1989;39:25-38
   PubMed Web of Science ®Google Scholar
• Kaiko RF, Benzinger DP, Fitzmartin RD, et al. Pharmacoltinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996;59:52-61
   PubMed Web of Science ®Google Scholar
• Orr WC, Chen CL. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol Gastrointest Liver Physiol 2002;283:G1226-31
   Google Scholar
• Gainsborough N, Maskrey VL, Nelson ML, et al. The association of age with gastric emptying. Age Ageing 1993;22:37-40
   PubMed Web of Science ®Google Scholar
• Valentini L, Ramminger S, Haas V, et al. Small intestinal permeability in older adults. Physiol Rep 2014;2:e00281
   Google Scholar
• Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004;39:1731-8
   PubMed Web of Science ®Google Scholar
• Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 2008;7:205-20
   PubMed Web of Science ®Google Scholar
• Armbrecht HJ, Boltz MA, Kumar VB. Intestinal plasma membrane calcium pump protein and its induction by 1,25(OH)(2)D(3) decrease with age. Am J Physiol 1999;277:G41-7
   PubMed Web of Science ®Google Scholar
• Toyoshima M, Inada M, Kameyama M. Effects of aging on intracellular transport of vitamin B12 (B12) in rat enterocytes. J Nutr Sci Vitaminol(Tokyo) 1983;29:1-10
   PubMed Web of Science ®Google Scholar
• Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 1992;55:1203S-7S
   PubMed Web of Science ®Google Scholar
• Doherty M, Charman W. The mucosa of the small intestine. Clin Pharmacokinet 2002;41:235-53
   PubMed Web of Science ®Google Scholar
• Gupta S. P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy. Drugs Aging 1995;7:19-29
   PubMed Web of Science ®Google Scholar
• ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007;14:488-98
   PubMedGoogle Scholar
• Wilkinson GR. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev 1997;27:129-59
   PubMed Web of Science ®Google Scholar
• Wynne H. Drug metabolism and ageing. J Br Menopause Soc 2005;11:51-6
   PubMedGoogle Scholar
• Robertson DR, Waller DG, Renwick AG, George CF. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 1988;25:297-305
   PubMed Web of Science ®Google Scholar
• Kelly J, McGarry K, O’Malley K, O’Brien E. Bioavailability of labetalol increases with age. Br J Clin Pharmacol 1982;14:304-5
   PubMed Web of Science ®Google Scholar
• Storstein L, Larsen A, Midtbø K, Saevareid L. Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients. Acta Med Scand Suppl 1983;681:25-30
   Google Scholar
• Castleden C, George C. The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol 1979;7:49-54
   PubMed Web of Science ®Google Scholar
• Vestal R, Wood A, Branch R, et al. Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 1979;26:8
   PubMed Web of Science ®Google Scholar
• Colangelo PM, Blouin RA, Steinmetz JE, et al. Age and propranolol stereoselective disposition in humans. Clin Pharmacol Ther 1992;51:489-94
   PubMed Web of Science ®Google Scholar
• Schulz P, Turner-Tamiyasu K, Smith G, et al. Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther 1983;33:360-6
   PubMed Web of Science ®Google Scholar
• Nation R, Vine J, Triggs E, Learoyd B. Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects. Eur J Clin Pharmacol 1977;12:137-45
   PubMed Web of Science ®Google Scholar
• Taguchi M, Nozawa T, Mizumaki K, et al. Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients. Biol Pharm Bull 2004;27:1642-8
   PubMed Web of Science ®Google Scholar
• Baillie S, Bateman D, Coates P, Woodhouse K. Age and the pharmacokinetics of morphine. Age Ageing 1989;18:258-62
   PubMed Web of Science ®Google Scholar
• Leenen FH, Coletta E. Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension. J Cardiovasc Pharmacol 2010;56:669-75
   PubMed Web of Science ®Google Scholar
• Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007;21:217-30
   PubMed Web of Science ®Google Scholar
• Lees KR, Reid JL. Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin Pharmacol Ther 1987;41:597-602
   PubMed Web of Science ®Google Scholar
• Macdonald N, Sioufi A, Howie C, et al. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol 1993;36:205-9
   PubMed Web of Science ®Google Scholar
• Abe M, Smith J, Urae A, et al. Pharmacokinetics of oseltamivir in young and very elderly subjects. Ann Pharmacother 2006;40:1724-30
   PubMed Web of Science ®Google Scholar
• Warrington JS, Greenblatt DJ, von Moltke LL. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. J Pharmacol Exp Ther 2004;309:720-9
   PubMed Web of Science ®Google Scholar
• Palasz A, Wiaderkiewicz A, Wiaderkiewicz R, et al. Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine. Genes Nutr 2012;7:197-207
   PubMed Web of Science ®Google Scholar
• Bolling BW, Blumberg JB, Chen C-YO. Microsomal quercetin glucuronidation in rat small intestine depends on age and segment. Drug Metab Dispos 2011;39:1406-14
   PubMed Web of Science ®Google Scholar
• Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm 2008;65:2347-57
   PubMed Web of Science ®Google Scholar
• Elia M, Stratton R, Holden C, et al. Home artificial nutritional support: the value of the British Artificial Nutrition Survey. Clin Nutr 2001;20:61-6
   Web of Science ®Google Scholar
• Pironi L, Candusso M, Biondo A, et al. Prevalence of home artificial nutrition in Italy in 2005: a survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE). Clin Nutr 2007;26:123-32
   PubMed Web of Science ®Google Scholar
• Magnuson BL, Clifford TM, Hoskins LA, Bernard AC. Enteral nutrition and drug administration, interactions, and complications. Nutr Clin Pract 2005;20:618-24
   PubMedGoogle Scholar
• Bauer LA. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 1982;32:570-0
   PubMed Web of Science ®Google Scholar
• Yeung SCA, Ensom MH. Phenytoin and enteral feedings: does evidence support an interaction? Ann Pharmacother 2000;34:896-905
   PubMed Web of Science ®Google Scholar
• Lubart E, Berkovitch M, Leibovitz A, et al. Phenytoin blood concentrations in hospitalized geriatric patients: oral versus nasogastric feeding tube administration. Ther Drug Monit 2010;32:185-8
   PubMed Web of Science ®Google Scholar
• Lubart E, Berkovitch M, Leibovitz A, et al. Pharmacokinetics of ciprofloxacin in hospitalized geriatric patients: comparison between nasogastric tube and oral administration. Ther Drug Monit 2013;35:653-6
   PubMed Web of Science ®Google Scholar
• Fish DN, Abraham E. Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. Antimicrob Agents Chemother 1999;43:1277-80
   PubMed Web of Science ®Google Scholar
• Mitchell J. Oral dosage forms that should not be crushed. Last update: January 2014 Available from: www.ismp.org/tools/donotcrush.pdf
   Google Scholar
• Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N. Use of transdermal drug formulations in the elderly. Drugs Aging 2008;25:269-80
   PubMed Web of Science ®Google Scholar
• Roskos KV, Maibach HI, Guy RH. The effect of aging on percutaneous absorption in man. J Pharmacokinet Biopharm 1989;17:617-30
   PubMedGoogle Scholar
• Van Nimmen NF, Poels KL, Menten JJ, et al. Fentanyl transdermal absorption linked to pharmacokinetic characteristics in patients undergoing palliative care. J Clin Pharmacol 2010;50:667-78
   PubMed Web of Science ®Google Scholar
• Konda S, Meier-Davis SR, Cayme B, et al. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products. Skin Therapy Lett 2012;17:5-7
   PubMedGoogle Scholar
• Vanakoski J, Seppälä T. Heat exposure and drugs. Clin Pharmacokinet 1998;34:311-22
   PubMed Web of Science ®Google Scholar
• Luebberding S, Krueger N, Kerscher M. Age-related changes in skin barrier function - quantitative evaluation of 150 female subjects. Int J Cosmet Sci 2013;35:183-90
   PubMed Web of Science ®Google Scholar
• Pride N. Ageing and changes in lung mechanics. Eur Respir J 2005;26:563-5
   PubMed Web of Science ®Google Scholar
• Fain SB, Altes TA, Panth SR, et al. Detection of age-dependent changes in healthy adult lungs with diffusion-weighted 3He MRI. Acad Radiol 2005;12:1385-93
   PubMed Web of Science ®Google Scholar
• Gupta P, O’Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drugs Aging 2008;25:415-43
   PubMed Web of Science ®Google Scholar
• Crompton GK, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the aerosol drug management improvement team. Respir Med 2006;100:1479-94
   PubMed Web of Science ®Google Scholar
• Barrons R, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm 2011;68:1221-32
   PubMed Web of Science ®Google Scholar
• Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing 2003;32:299-302
   PubMed Web of Science ®Google Scholar
• Ho SF, O’Mahony MS, Steward JA, et al. Inhaler technique in older people in the community. Age Ageing 2004;33:185-8
   PubMed Web of Science ®Google Scholar
• Fulop TJr, Worum I, Csongor J, et al. Body composition in elderly people. I. Determination of body composition by multiisotope method and the elimination kinetics of these isotopes in healthy elderly subjects. Gerontology 1985;31:6-14
   PubMed Web of Science ®Google Scholar
• Kyle UG, Genton L, Hans D, et al. Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons. J Am Geriatr Soc 2001;49:1633-40
   PubMed Web of Science ®Google Scholar
• Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci 2001;56:B209-17
   PubMed Web of Science ®Google Scholar
• Thompson CM, Johns DO, Sonawane B, et al. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. J Toxicol Environ Health B Crit Rev 2009;12:1-24
   PubMed Web of Science ®Google Scholar
• Hughes VA, Roubenoff R, Wood M, et al. Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr 2004;80:475-82
   PubMed Web of Science ®Google Scholar
• Gába A, Přidalová M. Age-related changes in body composition in a sample of Czech women aged 18–89 years: a cross-sectional study. Eur J Nutr 2014;53:167-76
   PubMed Web of Science ®Google Scholar
• Sillanpää E, Cheng S, Häkkinen K, et al. Body composition in 18-to 88-year-old adults – comparison of multifrequency bioimpedance and dual-energy X-ray absorptiometry. Obesity 2014;22:101-9
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Morini P, Forti P, et al. Anthropometric characteristics of healthy Italian nonagenarians and centenarians. Br J Nutr 1997;77:9-17
   PubMed Web of Science ®Google Scholar
• Kuczmarski MF, Kuczmarski RJ, Najjar M. Descriptive anthropometric reference data for older Americans. J Am Diet Assoc 2000;100:59-66
   PubMed Web of Science ®Google Scholar
• Newman AB, Lee JS, Visser M, et al. Weight change and the conservation of lean mass in old age: the health, aging and body composition study. Am J Clin Nutr 2005;82:872-8
   PubMed Web of Science ®Google Scholar
• Mühlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology 1999;45:243-53
   PubMed Web of Science ®Google Scholar
• Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002;71:115-21
   PubMed Web of Science ®Google Scholar
• de Vries OJ, Peeters G, Elders P, et al. The elimination half-life of benzodiazepines and fall risk: two prospective observational studies. Age Ageing 2013;42:764-70
   PubMed Web of Science ®Google Scholar
• Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004;38:73-7
   PubMed Web of Science ®Google Scholar
• Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 2001;18:837-51
   PubMed Web of Science ®Google Scholar
• Greenblatt D. Reduced serum albumin concentration in the elderly: a report from the Boston collaborative drug surveillance program. J Am Geriatr Soc 1979;27:20-2
   PubMed Web of Science ®Google Scholar
• Campion EW, Delabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the normative aging study. J Gerontol 1988;43:M18-20
   PubMedGoogle Scholar
• Chin PKL, Jensen BP, Larsen HS, Begg EJ. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol 2011;72:985-9
   PubMed Web of Science ®Google Scholar
• Jensen BP, Chin PKL, Roberts RL, Begg EJ. Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin. Br J Clin Pharmacol 2012;74:797-805
   PubMed Web of Science ®Google Scholar
• Fu A, Nair KS. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol 1998;275:E1023-30
   PubMed Web of Science ®Google Scholar
• Gunasekera J, Lee D, Jones L, et al. Does albumin fall with increasing age in the absence of disease. Age Ageing 1996;25:P29
   Google Scholar
• Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet 2000;38:271-90
   PubMed Web of Science ®Google Scholar
• Butler J, Begg E. Free drug metabolic clearance in elderly people. Clin Pharmacokinet 2008;47:297-321
   PubMed Web of Science ®Google Scholar
• Patterson M, Heazelwood R, Smithurst B, Eadie M. Plasma protein binding of phenytoin in the aged: in vivo studies. Br J Clin Pharmacol 1982;13:423-5
   PubMed Web of Science ®Google Scholar
• Boudinot SG, Funderburg ED, Boudinot FD. Effects of age on the pharmacokinetics of piroxicam in rats. J Pharm Sci 1993;82:254-7
   PubMed Web of Science ®Google Scholar
• Karim A, Noveck R, McMahon FG, et al. Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics. J Clin Pharmacol 1997;37:267-78
   PubMed Web of Science ®Google Scholar
• Cusack B, O’Malley K, Lavan J, et al. Protein binding and disposition of lignocaine in the elderly. Eur J Clin Pharmacol 1985;29:323-9
   PubMed Web of Science ®Google Scholar
• Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26:144-60
   PubMed Web of Science ®Google Scholar
• Anders M. Metabolism of drugs by the kidney. Kidney Int 1980;18:636-47
   PubMed Web of Science ®Google Scholar
• Hiraoka H, Yamamoto K, Miyoshi S, et al. Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. Br J Clin Pharmacol 2005;60:176-82
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, McLean AJ. The aging liver. Clin Pharmacokinet 1998;34:359-73
   PubMed Web of Science ®Google Scholar
• Cotreau MM, von Moltke LL, Greenblatt DJ. The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet 2005;44:33-60
   PubMed Web of Science ®Google Scholar
• Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989;9:297-301
   PubMed Web of Science ®Google Scholar
• Zoli M, Magalotti D, Bianchi G, et al. Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing 1999;28:29-33
   PubMed Web of Science ®Google Scholar
• Zeeh J, Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002;48:121-7
   PubMed Web of Science ®Google Scholar
• Woodhouse K, Wynne H. Age-related changes in liver size and hepatic blood flow. Clin Pharmacokinet 1988;15:287-94
   PubMed Web of Science ®Google Scholar
• McLachlan AJ, Pont LG. Drug metabolism in older people – a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci 2012;67:175-80
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, Fraser R, Kilmer S, et al. The hepatic sinusoid in aging and cirrhosis. Clin Pharmacokinet 2005;44:187-200
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, Warren A, Cogger VC, et al. Old age and the hepatic sinusoid. Anat Rec 2008;291:672-83
   Google Scholar
• Hilmer SN, Cogger VC, Fraser R, et al. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 2005;42:1349-54
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Cogger VC, Muller M, Le Couteur DG. The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin. Drug Metab Dispos 2004;32:794-9
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Huizer-Pajkos A, Cogger VC, et al. Age-related pseudocapillarization of the liver sinusoidal endothelium impairs the hepatic clearance of acetaminophen in rats. J Gerontol A Biol Sci Med Sci 2011;66A:400-8
   Google Scholar
• Mitchell SJ, Huizer-Pajkos A, Cogger VC, et al. The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver. Pharmacology 2012;90:233-41
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, et al. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 2004;199:193-209
   PubMed Web of Science ®Google Scholar
• Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions[ast]. Clin Pharmacol Ther 1997;61:331-9
   PubMed Web of Science ®Google Scholar
• Battino D, Croci D, Mamoli D, et al. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Epilepsy Res 2004;59:155-65
   PubMed Web of Science ®Google Scholar
• Bebia Z, Buch SC, Wilson JW, et al. Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol Ther 2004;76:618-27
   PubMed Web of Science ®Google Scholar
• Schmucker DL. Age-related changes in liver structure and function: implications for disease? Exp Gerontol 2005;40:650-9
   PubMed Web of Science ®Google Scholar
• Twum-Barima Y, Finnigan T, Habash AI, et al. Impaired enzyme induction by rifampicin in the elderly. Br J Clin Pharmacol 1984;17:595-7
   PubMed Web of Science ®Google Scholar
• Kinirons M, O’Mahony M. Drug metabolism and ageing. Br J Clin Pharmacol 2004;57:540-4
   PubMed Web of Science ®Google Scholar
• Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011;9:364-77
   PubMed Web of Science ®Google Scholar
• Fromm MF, Dilger K, Busse D, et al. Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction. Br J Clin Pharmacol 1998;45:247-55
   PubMed Web of Science ®Google Scholar
• Herd B, Wynne H, Wright P, et al. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br J Clin Pharmacol 1991;32:768-70
   PubMed Web of Science ®Google Scholar
• Court MH. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 2010;42:209-24
   PubMed Web of Science ®Google Scholar
• Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. J Pharm Sci 1981;70:1104-7
   PubMed Web of Science ®Google Scholar
• Ghabrial H, Desmond P, Watson K, et al. The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol 1986;30:93-7
   PubMed Web of Science ®Google Scholar
• Smith R, Divoll M, Gillespie W, Greenblatt D. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. J Clin Psychopharmacol 1983;3:172-5
   PubMed Web of Science ®Google Scholar
• Wynne HA, Cope LH, Herd B, et al. The association of age and frailty with paracetamol conjugation in man. Age Ageing 1990;19:419-24
   PubMed Web of Science ®Google Scholar
• Wynne H, Yelland C, Cope L, et al. The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide. Age Ageing 1993;22:354-9
   PubMed Web of Science ®Google Scholar
• Williams F, Wynne H, Woodhouse K, Rawlins M. Plasma aspirin esterase: the influence of old age and frailty. Age Ageing 1989;18:39-42
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res 2011;2011:624156
   PubMedGoogle Scholar
• Fliser D, Franek E, Ritz E. Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transplant 1997;12:1553-5
   PubMed Web of Science ®Google Scholar
• Sesso R, Prado F, Vicioso B, Ramos LR. Prospective study of progression of kidney dysfunction in community-dwelling older adults. Nephrology 2008;13:99-103
   PubMed Web of Science ®Google Scholar
• Tsaih S-W, Korrick S, Schwartz J, et al. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect 2004;112(11):1178-82
   PubMed Web of Science ®Google Scholar
• Loboz KK, Shenfield GM. Drug combinations and impaired renal function–the ‘triple whammy’. Br J Clin Pharmacol 2005;59:239-43
   PubMed Web of Science ®Google Scholar
• Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 2013;346:e8525
   PubMed Web of Science ®Google Scholar
• Lindeman R, Tobin J, Shock N. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85
   PubMed Web of Science ®Google Scholar
• Aymanns C, Keller F, Maus S, et al. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clin J Am Soc Nephrol 2010;5:314-27
   PubMed Web of Science ®Google Scholar
• Keller F, Frankewitsch T, Zellner D, et al. Standardized structure and modular design of a pharmacokinetic database. Comput Methods Programs Biomed 1998;55:107-15
   PubMed Web of Science ®Google Scholar
• Fliser D, Zeier M, Nowack R, Ritz E. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993;3:1371-7
   PubMed Web of Science ®Google Scholar
• Esposito C, Plati A, Mazzullo T, et al. Renal function and functional reserve in healthy elderly individuals. J Nephrol 2007;20:617-25
   PubMed Web of Science ®Google Scholar
• Schmitt R, Coca S, Kanbay M, et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008;52:262-71
   PubMed Web of Science ®Google Scholar
• Johnston C, Hilmer S, McLachlan A, et al. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol 2014;70:549-55
   PubMed Web of Science ®Google Scholar
• Lionakis N, Mendrinos D, Sanidas E, et al. Hypertension in the elderly. World J Cardiol 2012;4:135
   PubMedGoogle Scholar
• Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012;35:2650-64
   PubMed Web of Science ®Google Scholar
• Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47
   PubMed Web of Science ®Google Scholar
• Lassiter J, Bennett WM, Olyaei AJ. Drug Dosing in Elderly Patients with Chronic Kidney Disease. Clin Geriatr Med 2013;29:657-705
   PubMed Web of Science ®Google Scholar
• Stevens LA, Padala S, Levey AS. Advances in glomerular filtration rate estimating equations. Curr Opin Nephrol Hypertens 2010;19:298
   PubMed Web of Science ®Google Scholar
• Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD epidemiology collaboration (CKD-EPI) and the modification of diet in renal disease (MDRD) study equations for estimating GFR levels Above 60 mL/min/1.73m2. Am J Kidney Dis 2010;56:486-95
   PubMed Web of Science ®Google Scholar
• van Bemmel T, Woittiez K, Blauw GJ, et al. Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-plus study. J Am Soc Nephrol 2006;17:2561-6
   PubMed Web of Science ®Google Scholar
• Nolin T, Naud J, Leblond F, Pichette V. Emerging evidence of the impact of kidney disease on drug metabolism and transport. Clin Pharmacol Ther 2008;83:898-903
   PubMed Web of Science ®Google Scholar
• Dreisbach AW, Lertora JJ. The effect of chronic renal failure on drug metabolism and transport. Expert Opin Drug Metab Toxicol 2008;4:1065-74
   PubMed Web of Science ®Google Scholar
• Barnes KJ, Rowland A, Polasek TM, Miners JO. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins. Eur J Clin Pharmacol 2014;70:1097-106
   PubMed Web of Science ®Google Scholar
• Naud J, Michaud J, Beauchemin S, et al. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos 2011;39:1363-9
   PubMed Web of Science ®Google Scholar
• Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer. Oncology (Williston Park) 2008;22:56-61
   PubMed Web of Science ®Google Scholar
• Plummer JL, Gourlay GK, Cherry DA, Cousins MJ. Estimation of methadone clearance: application in the management of cancer pain. Pain 1988;33:313-22
   PubMed Web of Science ®Google Scholar
• Modesto-Lowe V, Brooks D, Petry N. Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med 2010;25:305-9
   PubMed Web of Science ®Google Scholar
• Polasek TM, Patel F, Jensen BP, et al. Predicted metabolic drug clearance with increasing adult age. Br J Clin Pharmacol 2013;75:1019-28
   PubMed Web of Science ®Google Scholar
• Strougo A, Yassen A, Krauwinkel W, et al. A semiphysiological population model for prediction of the pharmacokinetics of drugs under liver and renal disease conditions. Drug Metab Dispos 2011;39:1278-87
   PubMed Web of Science ®Google Scholar